Haynes and Boone represented Serenity Kids in the transaction, and Latham & Watkins represented Stride Consumer Partners. Serenity Kids, a shelf-stable pouched baby food brand, announced...
Serenity Kids’ $52 Million Series B Funding Round
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
IGT’s US$6.2 Billion Business Combination of Its Global Gaming Business with Everi
Sidley Austin LLP and White & Case LLP are serving as legal counsel to IGT, Wachtell, Lipton, Rosen & Katz is serving as counsel to IGT...
Sea Machines’ $12 Million Funding Round
Pillsbury Winthrop Shaw Pittman LLP advised Chevron Technology Ventures on its recent investment into Sea Machines. Sea Machines, a developer of autonomous control systems and advanced...
TD SYNNEX’s $885 Million Secondary Public Offering
Pillsbury Winthrop Shaw Pittman LLP advised TD SYNNEX Corporation on the matter. TD SYNNEX Corporation (NYSE: SNX) announced the pricing of the previously announced secondary public...
Alpine Immune Sciences’ $150 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised Alpine Immune Sciences on the offering, and Latham & Watkins advised the underwriters. Alpine Immune Sciences, Inc. (Nasdaq: ALPN) announced the...
LegalZoom’s $140 Million Secondary Offering of Common Stock
Cooley advised LegalZoom, Latham advised the underwriters, and Fried Frank advised the selling stockholder on the offering. LegalZoom.com, Inc. (Nasdaq: LZ) priced the previously announced underwritten...
Zevra Therapeutics’ $91 Million Acquisition of Acer Therapeutics
Bryan Cave is advising Zevra, and Pillsbury is advising Acer Therapeutics. Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) and Acer Therapeutics Inc. (Nasdaq: ACER) announced the companies have entered into...
e.l.f. Beauty’s US$355 Million Acquisition of Naturium
Latham & Watkins advises e.l.f. Beauty in its acquisition of Naturium. e.l.f. Beauty (NYSE: ELF) has announced it has signed a definitive agreement to acquire Naturium,...
WestView Capital Partners’ investment in Hubstaff
Latham & Watkins advises WestView Capital Partners in its investment in Hubstaff WestView Capital Partners made a strategic investment in Hubstaff as the workforce management software company capitalizes...
Ikena Oncology’s Acquisition of Pionyr Immunotherapeutics
Latham & Watkins advised Pionyr on the sale. Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of...
Revolution Medicines’ Acquisition of EQRx
Latham & Watkins advises Revolution Medicines on the deal, and Goodwin Procter advises EQRx. Revolution Medicines, Inc. (Nasdaq: RVMD) and EQRx, Inc. (Nasdaq: EQRX) announced a definitive agreement...